在BRIGHT-4试验后的STEMI中,比瓦利鲁丁与肝素对比:更新的元分析
Prakash Raj Oli1, Dhan Bahadur Shrestha2, Jurgen Shtembari2
1Department of Internal Medicine, Karnali Province Hospital, Birendranagar, Nepal.
Coronary artery disease
|October 22, 2023
概括
与肝素相比,比瓦利鲁丁抗凝剂在接受皮肤冠状动脉干预的ST升高心肌梗塞患者中显著降低了不良事件和死亡率. 这种方法可以改善心血管结果,而不会增加血栓形成的风险.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学 是一个学科.
- 干预心脏病学 干预心脏病学
背景情况:
- 在ST升高心肌梗塞 (STEMI) 中进行皮肤冠状动脉干预 (PCI) 的最佳抗凝策略仍然是正在进行的研究的主题.
- 比瓦利鲁丁已经成为传统的基于氨酸的抗凝药的潜在替代品,最近的试验如BRIGHT-4提供了新的证据.
- 这一元分析专门研究了接受PCI的STEMI群体.
研究的目的:
- 在接受PCI的STEMI患者中进行元分析,评估基于比瓦利鲁丁的抗凝剂与基于肝素的抗凝剂的疗效和安全性.
- 综合来自多个随机对照试验的证据,以提供对临床结果的全面评估.
主要方法:
- 遵守PRISMA指南和PROSPERO注册 (CRD42023394701) 的要求.
- 对2023年1月之前发表的相关研究的数据库进行系统的文献搜索.
- 从13项随机对照试验中提取和分析数据,其中包括24,360名STEMI患者,使用RevMan v5.4软件.
主要成果:
- 比瓦利鲁丁显著减少了净临床事件 (OR 0.75),主要心脏或大脑不良事件 (OR 0.85) 和所有出血事件 (OR 0.61),包括主要出血 (OR 0.54).
- 随着比瓦利鲁丁的使用,观察到所有原因死亡率 (OR 0.79) 和心脏死亡率 (OR 0.78) 的显著降低.
- 在30天后,没有发现任何支架血栓 (OR 0.92),确定的支架血栓 (OR 1.17) 或急性支架血栓 (OR 2.06) 的风险显著增加.
结论:
- 比瓦利鲁丁,特别是PCI后的高剂量输液,在STEMI PCI中比肝素提供了显著的心血管益处.
- 比瓦利鲁丁的使用不会导致血栓性并发症的显著增加.
- 这一元分析支持比瓦利鲁丁作为接受PCI的STEMI患者的有利抗凝策略.
相关概念视频
01:29Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
723
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
723
01:30Acute Coronary Syndrome I: Introduction
30
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
30
01:30Acute Coronary Syndrome III: Diagnostic Studies
9
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
9
01:28Acute Coronary Syndrome IV: Interprofessional Care
11
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
11
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
10
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
10